(INNS)
BIMAGRUMAB(INND)
BIMAGRUMAB(INNC)
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-[HOMO SAPIENS ACVR2B (ACTIVIN A RECEPTOR TYPE IIB, ACTR-IIB, ACTRIIB) AND ACVR2A (ACTIVIN A RECEPTOR TYPE IIA, ACTR-II, ACTRIIA)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-445) [HOMO SAPIENS VH (IGHV1-2*02 (91.80%) -(IGHD)-IGHJ5*01 [8.8.8] (1-115) -IGHG1*03 (CH1 (116- 213), HINGE (214-228), CH2 L1.3>A (232), L1.2>A (233) (229-338), CH3 (339-443), CHS (444-445)) (116-445)], (218-216')-DISULFIDE WITH LAMBDA LIGHT CHAIN (1'-217') [HOMO SAPIENS V-LAMBDA (IGLV2- 23*02 (90.90%) -IGLJ2*01) [9.3.11] (1'-111') -IGLC2*01 (112'-217')]; DIMER (224-224'':227-227'')-BISDISULFIDE, RECOMMENDED INN: LIST 70(WHO)
BIMAGRUMABUM(INN)